Startups channel feed – Endpoints News

Startups channel feed

Barcelona VC firm Asabys raises second fund, adding to Europe’s biotech funding scene

8 months ago

Next-gen obesity biotech BioAge Labs to raise $198M in IPO

8 months ago

Italian gene therapy startup nabs $52M for rare genetic disease that Moderna is working on

8 months ago

Checking up on past Endpoints 11 winners: Who went public, who got bought and who's still working

8 months ago

Clive Meanwell's new obesity biotech, Metsera, unveils early GLP-1 data with an eye on Phase 3 next year

8 months ago

Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board

8 months ago

UK vaccine startup Vicebio snags $100M to take on GSK, Pfizer and Moderna

8 months ago

Biotech VC firm outlines plans for $100M fund

8 months ago

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

8 months ago

Stem cell startup spun out of George Church’s lab raises $75M

8 months ago

23andMe heads to ESMO to tout its two clinical-stage drugs after scrapping discovery team

8 months ago

Ochre Bio CEO Jack O’Meara steps down, outlines plans for next startup

8 months ago

Biotech IPO market still in flux following flashy Friday tripleheader

8 months ago

Bicara, Zenas and MBX rekindle IPO market with rare Friday tripleheader

8 months ago

Sofinnova’s Jim Healy on ‘more rational market’ as four biotech startups near their IPOs

8 months ago

A new startup wants to fight cancer with 'off-the-shelf' gene therapy, securing $26M seed round

8 months ago

F2G inks $100M Series H for another shot at treating fungal infections

8 months ago

Radiant Bio snags $35M for antibody platform, with GSK and Regeneron partnerships

8 months ago

Exclusive: A male contraceptive may prevent 99% of pregnancies. Now it’s up to a small biotech to finish testing it

8 months ago

Exclusive: Bain scoops up $3B for fourth life sciences fund after handful of M&A deals

8 months ago

A General Catalyst-backed startup raised $38M to help workers buy health coverage on their own

8 months ago

Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success

9 months ago

MBX seeks $114M IPO to compete with Ascendis and get a long-acting GLP-1/GIP prodrug into the clinic

9 months ago

Non-viral delivery startup Vesigen Therapeutics trims staff as it evaluates 'strategic options'

9 months ago

First page Previous page 10 11 121314 15 16 Next page Last page